# MyHealingCommunity

## Home

- [Home](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/readme.md): Evidence-based guide to anti-cancer compounds, molecules, support resources, and community discussion directories in integrative oncology
- [Resistant Starch](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/resistant-starch.md): Practical guide to resistant starch, food preparation, butyrate production, and why cooling cooked starches can change both glycaemic and gut effects
- [Senolytic Pulse Protocol](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/senolytic-pulse-protocol.md): Conservative, patient-facing framework for intermittent natural senolytic-style pulses built around fisetin and quercetin, with apigenin adding extra pressure on escape routes
- [Macrophages in Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/macrophages-in-cancer.md): A quick guide to macrophages in cancer, including immune coordination, recovery time, and why washout windows can matter.
- [Understanding the M1 / M2 Story More Carefully](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/macrophages-in-cancer/understanding-the-m1-m2-story-more-carefully.md): A guide to macrophage polarization, why M1/M2 labels can mislead, and how context changes the meaning.
- [Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/overview.md): Overview of the natural medicines library, including compound hubs such as Withaferin A and practical guidance on liposomal delivery
- [Direct links to our natural medicines in oncology deep dives and FB group's conversation threads](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/direct-links-to-our-natural-medicines-in-oncology-deep-dives-and-fb-groups-conversation-threads.md): Overview of the natural medicines library, including deep dives, liposomal delivery guidance, and the A–Z group discussion thread index
- [Berberine in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology.md): Deep-dive guide to berberine in oncology, including mechanisms, evidence summary, pharmacology context, and safety cautions
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/evidence-summary.md): Evidence-based summary of berberine in oncology, including strengths, limits, clinical positioning, and key treatment considerations
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/anticancer-mechanisms.md): Primary anti-cancer mechanisms of berberine and why they matter in oncology research
- [Redox Dual Action](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/anticancer-mechanisms/redox-dual-action.md): Context-dependent oxidative and antioxidant activity of berberine in cancer biology
- [Glucose, Glutamine & the Warburg Effect](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/anticancer-mechanisms/glucose-glutamine-and-the-warburg-effect.md): How berberine disrupts glucose uptake, glycolysis, and glutamine dependence in cancer cells
- [Ferroptosis Findings](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/anticancer-mechanisms/ferroptosis-findings.md): Emerging evidence that berberine can promote ferroptosis in selected cancer models
- [NRF2 Impact](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/anticancer-mechanisms/nrf2-impact.md): Context-dependent berberine effects on the Nrf2 pathway and why that matters in oncology
- [Berberine Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/berberine-evidence-by-cancer-type.md): Cancer-type guide to berberine in oncology research, including colorectal, breast, lung, gastric, gynaecological, and brain-tumour evidence
- [Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/berberine-evidence-by-cancer-type/breast-cancer.md): Evidence-based overview of berberine in breast cancer, including TNBC, ER-positive, and HER2-positive resistance-reversal research
- [Lung Cancer (NSCLC)](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/berberine-evidence-by-cancer-type/lung-cancer-nsclc.md): Evidence-based overview of berberine in non-small-cell lung cancer, including p53-independent growth arrest, cancer-stem-cell effects, and ferroptosis-linked findings
- [Gastric Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/berberine-evidence-by-cancer-type/gastric-cancer.md): Evidence-based overview of berberine in gastric cancer, including JAK2/STAT3 inhibition, glycolysis effects, and low-glucose synergy
- [Colorectal Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/berberine-evidence-by-cancer-type/colorectal-cancer.md): Evidence-based overview of berberine in colorectal cancer, including adenoma-prevention data, microbiome relevance, and cetuximab-sensitisation research
- [Gynaecological Cancers](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/berberine-evidence-by-cancer-type/gynaecological-cancers.md): Evidence-based overview of berberine in ovarian, cervical, and endometrial cancers, including metastasis, HPV, and PI3K/Akt-related findings
- [Glioblastoma & Brain Tumours](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/berberine-evidence-by-cancer-type/glioblastoma-and-brain-tumours.md): Evidence-based overview of berberine in glioblastoma and brain-tumour research, including autophagy, glycolysis pressure, and delivery challenges
- [Immune Effects](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/immune-effects.md): How berberine may remodel the tumour microenvironment, reduce PD-L1 signalling, and support anti-tumour immunity
- [Antimicrobial / Antifungal Activity](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/antimicrobial-antifungal-activity.md): Berberine's antimicrobial and antifungal activity, including H. pylori, Fusobacterium nucleatum, Candida, and microbiome relevance in oncology
- [Pharmacokinetics & Metabolism](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/pharmacokinetics-and-metabolism.md): Berberine bioavailability limits, gut-microbiome conversion, tissue distribution, and formulation considerations in oncology
- [Safety & Interactions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/safety-and-interactions.md): Berberine safety profile, CYP and P-glycoprotein interaction risks, and monitoring considerations in oncology
- [Dosing & Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/dosing-and-timing.md): Berberine dosing ranges, meal timing, fasting context, and formulation-adjusted use in oncology discussions
- [Berberine & Metformin](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/berberine-in-oncology/berberine-and-metformin.md): Why berberine and metformin are usually better used as a continuous metabolic backbone rather than alternated in cycles
- [Boswellia in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology.md)
- [Boswellia in Oncology Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-in-oncology-overview.md): What Boswellia is, how it relates to frankincense, and why AKBA matters in oncology
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/evidence-summary.md): Evidence-based summary of Boswellia in oncology, including AKBA strengths, clinical positioning, and treatment considerations
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/anticancer-mechanisms.md): Primary anti-cancer mechanisms of Boswellia and AKBA in oncology research
- [Boswellia Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type.md): Cancer-type guide to Boswellia in oncology, including glioblastoma, breast, colorectal, pancreatic, prostate, lung, ovarian, and related research
- [Glioblastoma & Brain Tumours](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/glioblastoma-and-brain-tumours.md): Evidence-based overview of Boswellia in glioblastoma and brain tumours, including cerebral oedema and radiosensitisation relevance
- [Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/breast-cancer.md): Evidence-based overview of Boswellia in breast cancer, including Phase Ia human data, EGFR signalling, and apoptosis research
- [Colorectal Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/colorectal-cancer.md): Evidence-based overview of Boswellia in colorectal cancer, including orthotopic model data, miRNA effects, and invasion suppression
- [Pancreatic Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/pancreatic-cancer.md): Evidence-based overview of Boswellia in pancreatic cancer, including orthotopic tumour suppression and COX-2-related mechanisms
- [Prostate Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/prostate-cancer.md): Evidence-based overview of Boswellia in prostate cancer, including docetaxel-resistance reversal and Akt / STAT3 suppression
- [Non-Small Cell Lung Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/non-small-cell-lung-cancer.md): Evidence-based overview of Boswellia in NSCLC, including cisplatin sensitisation and radioresistance reversal
- [Ovarian Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/ovarian-cancer.md): Evidence-based overview of Boswellia in ovarian cancer, including taxane-resistance and multidrug-resistance findings
- [Other Cancer Types](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/boswellia-evidence-by-cancer-type/other-cancer-types.md): Additional Boswellia oncology evidence across liver, gastric, haematologic, melanoma, and other cancer models
- [Redox Dual Action](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/redox-dual-action.md): Context-dependent oxidative and anti-inflammatory activity of Boswellia and AKBA
- [NRF2 Impact](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/nrf2-impact.md): Context-dependent Nrf2 interpretation for Boswellia and AKBA in oncology
- [Ferroptosis Findings](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/ferroptosis-findings.md): Emerging ferroptosis relevance of Boswellia and AKBA in resistant tumour biology
- [Immune Effects](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/immune-effects.md): How Boswellia/AKBA modulates inflammatory mediators and anti-tumour immune function
- [Pharmacokinetics & Metabolism](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/pharmacokinetics-and-metabolism.md): How Boswellia and AKBA are absorbed, metabolised, and limited by bioavailability
- [Safety & Interactions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/safety-and-interactions.md): Safety profile, CYP interactions, anticoagulant cautions, and monitoring considerations for Boswellia in oncology
- [Synergistic Combinations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/synergistic-combinations.md): How Boswellia and AKBA may combine with chemotherapy, radiotherapy, and other natural compounds
- [Hydroxychloroquine + Boswellia](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/hydroxychloroquine-+-boswellia.md): Special report on hydroxychloroquine and Boswellia / AKBA as a dual autophagy-blocking strategy, including prostate-cancer evidence and cardiac cautions
- [Dosing & Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/dosing-and-timing.md): Boswellia and AKBA dosing logic, clinical trial ranges, food timing, and formulation considerations
- [Sourcing Quality Boswellia](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/boswellia-in-oncology/sourcing-quality-boswellia.md): How to judge Boswellia extract quality, AKBA standardisation, and formulation relevance for oncology-oriented use
- [Curcumin in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology.md)
- [Curcumin in Oncology Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/curcumin-in-oncology-overview.md): What curcumin is, why it is studied in oncology, and where the evidence is strongest across prevention and adjunctive care
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/evidence-summary.md): Evidence-based summary of curcumin in oncology, including clinical positioning, advantages, limitations, and treatment considerations
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/anticancer-mechanisms.md): Primary anti-cancer mechanisms of curcumin
- [Redox Dual Action](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/anticancer-mechanisms/redox-dual-action.md): Context-dependent curcumin redox activity explaining selective toxicity toward cancer cells
- [NRF2 Impact](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/anticancer-mechanisms/nrf2-impact.md): Curcumin's activation of the Nrf2 pathway and why it matters clinically
- [Ferroptosis Findings](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/anticancer-mechanisms/ferroptosis-findings.md): Emerging evidence that curcumin can induce ferroptosis in resistant cancer cells
- [Curcumin Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/curcumin-evidence-by-cancer-type.md): Cancer-type guide to curcumin in oncology, including colorectal, breast, pancreatic, lung, prostate, gastric, head and neck, and blood cancer research
- [Blood Cancers](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/curcumin-evidence-by-cancer-type/blood-cancers.md): Evidence-based overview of curcumin in blood cancers, including myeloma, CLL, ALL, and lymphoma research
- [Colorectal Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/curcumin-evidence-by-cancer-type/colorectal-cancer.md): Evidence-based overview of curcumin in colorectal cancer, including chemoprevention, FOLFOX synergy, stem-cell targeting, and resistance data
- [Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/curcumin-evidence-by-cancer-type/breast-cancer.md): Evidence-based overview of curcumin in breast cancer, including subtype-specific data, taxane synergy, radiotherapy support, and resistance research
- [Pancreatic Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/curcumin-evidence-by-cancer-type/pancreatic-cancer.md): Evidence-based overview of curcumin in pancreatic cancer, including Phase II clinical data and gemcitabine-sensitising research
- [Lung Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/curcumin-evidence-by-cancer-type/lung-cancer.md): Evidence-based overview of curcumin in lung cancer and other lung cancers: mechanisms, preclinical findings, and clinical direction
- [Prostate Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/curcumin-evidence-by-cancer-type/prostate-cancer.md): Evidence-based overview of curcumin in prostate cancer: human trial data, pathway-specific mechanisms, and honest assessment of the evidence
- [Head & Neck Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/curcumin-evidence-by-cancer-type/head-and-neck-cancer.md): Evidence-based overview of curcumin in head and neck cancer, including mucositis support and anti-metastatic findings
- [Gastric Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/curcumin-evidence-by-cancer-type/gastric-cancer.md): Evidence-based overview of curcumin in gastric cancer, including H. pylori relevance and inflammation-linked mechanisms
- [Immune Effects](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/immune-effects.md): How curcumin may support anti-tumour immune function
- [Antimicrobial / Antifungal Activity](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/antimicrobial-antifungal-activity.md): Curcumin's antimicrobial properties and their possible relevance to cancer biology
- [Pharmacokinetics & Metabolism](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/pharmacokinetics-and-metabolism.md): Curcumin bioavailability, drug interactions, and delivery considerations
- [Dosing & Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/dosing-and-timing.md): Curcumin timing, dosing logic, and clinically relevant formulation considerations
- [Safety & Interactions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/safety-and-interactions.md): Curcumin safety profile, contraindications, and monitoring considerations
- [Synergistic Combinations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/synergistic-combinations.md): Curcumin combinations with chemotherapy and natural compounds
- [Sourcing Quality Curcumin](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/curcumin-in-oncology/sourcing-quality-curcumin.md): How to judge curcumin supplement quality, bioavailability, actual curcuminoid strength, and real-world value for oncology-oriented use
- [Deuterium-Depleted Water (DDW)](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/deuterium-depleted-water-ddw.md): DDW section landing page covering what it is, why it matters in oncology, protocol questions, evidence by cancer type, and where to jump next
- [DDW Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/deuterium-depleted-water-ddw/ddw-evidence-by-cancer-type.md): Cancer-type guide to DDW in oncology research, including pancreatic, colorectal, breast, lung, nasopharyngeal, prostate, and mixed-clinical settings
- [DDW and Pancreatic Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/deuterium-depleted-water-ddw/ddw-evidence-by-cancer-type/ddw-and-pancreatic-cancer.md): Evidence-based overview of DDW in pancreatic cancer, including the 2021 adjunctive chemotherapy survival study and its limits
- [DDW Protocol Variation and Lower Limits](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/deuterium-depleted-water-ddw/ddw-protocol-variation-and-lower-limits.md): Why DDW experts differ on how low to go, including the Somlyai step-down model, the ~80 ppm caution, and the glycocalyx theory
- [DDW Sourcing and Brand Options](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/deuterium-depleted-water-ddw/ddw-sourcing-and-brand-options.md): Practical guide to DDW product formats, ppm options, mixing logic, and how to think about brands without overstating differences
- [EGCG in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology.md)
- [EGCG in Oncology Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/egcg-in-oncology-overview.md): What EGCG is, how it relates to green tea, and why it is studied in oncology
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/evidence-summary.md): Evidence-based summary of EGCG in oncology, including clinical positioning, strengths, limitations, and treatment considerations
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/anticancer-mechanisms.md): Primary anti-cancer mechanisms of EGCG and the green tea catechin evidence base
- [EGCG Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/egcg-evidence-by-cancer-type.md): Cancer-type guide to EGCG in oncology, including breast, pancreatic, colorectal, lung, prostate, blood, and oral cancer research
- [Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/egcg-evidence-by-cancer-type/breast-cancer.md): Evidence-based overview of EGCG in breast cancer, including subtype-specific data, treatment synergy, and recurrence-related research
- [Pancreatic Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/egcg-evidence-by-cancer-type/pancreatic-cancer.md): Evidence-based overview of EGCG in pancreatic cancer, including gemcitabine synergy and tumour-growth inhibition research
- [Colorectal Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/egcg-evidence-by-cancer-type/colorectal-cancer.md): Evidence-based overview of EGCG in colorectal cancer, including chemoprevention, local GI relevance, and 5-FU-related research
- [Lung Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/egcg-evidence-by-cancer-type/lung-cancer.md): Evidence-based overview of EGCG in lung cancer, including EGFR relevance, NSCLC research, and ferroptosis-related findings
- [Prostate Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/egcg-evidence-by-cancer-type/prostate-cancer.md): Evidence-based overview of EGCG in prostate cancer, including prevention trials, biomarker effects, and androgen-related relevance
- [Blood Cancers](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/egcg-evidence-by-cancer-type/blood-cancers.md): Evidence-based overview of EGCG in blood cancers, including CLL, leukaemia, lymphoma, and bortezomib-related cautions
- [Oral / Head & Neck Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/egcg-evidence-by-cancer-type/oral-head-and-neck-cancer.md): Evidence-based overview of EGCG in oral and head and neck cancers, including topical relevance and invasion-related findings
- [Other Cancer Types](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/egcg-evidence-by-cancer-type/other-cancer-types.md): Additional EGCG oncology evidence across ovarian, gastric, liver, and other cancer models
- [Immune Effects](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/immune-effects.md): How EGCG and the main green tea catechin may support anti-tumour immune function
- [Pharmacokinetics & Metabolism](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/pharmacokinetics-and-metabolism.md): How EGCG is absorbed, metabolised, and limited by poor oral bioavailability in oncology use
- [Dosing & Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/dosing-and-timing.md): EGCG dosing logic for prevention, adjunctive use, bioavailability, and treatment timing
- [Safety & Interactions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/safety-and-interactions.md): Safety profile, liver risk, drug interactions, and bortezomib caution for EGCG in oncology
- [Sourcing Quality EGCG](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/egcg-in-oncology/sourcing-quality-egcg.md): How to judge EGCG supplement quality, green tea extract strength, caffeine issues, and bioavailability considerations
- [Liposomal Encapsulation of Anti-cancer Compounds](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds.md): Why empty liposomes matter, how to use them, and safety-focused guides to liposomal melatonin and ivermectin
- [Why Empty Liposomes Matter](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds/why-empty-liposomes-matter.md): Why empty phosphatidylcholine liposomes may have biological activity of their own, and why that matters here
- [Safety, Timing, and Stacking Cautions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds/safety-timing-and-stacking-cautions.md): Key safety considerations when combining liposomal delivery with lipophilic drugs or supplements
- [How to Use Liposence® Empty Liposomes](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds/how-to-use-liposence-r-empty-liposomes.md): Practical notes on choosing ingredients, mixing, storage, and everyday use of Liposence empty liposomes
- [DIY Liposomal Melatonin](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds/diy-liposomal-melatonin.md): Recipe notes, costing logic, storage, and comparison points for DIY liposomal melatonin using empty liposomes
- [Liposomal Ivermectin](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds/liposomal-ivermectin.md): Experimental evidence, formulation notes, recipe math, and safety cautions for liposomal ivermectin
- [Nebulising Liposomal Formulations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/liposomal-encapsulation-of-anti-cancer-compounds/nebulising-liposomal-formulations.md): Advanced note on nebulised liposomal delivery, with pulmonary uptake, retention, and safety references
- [Polydatin in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology.md)
- [Polydatin in Oncology Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-in-oncology-overview.md): What polydatin is and where the evidence is strongest in oncology research.
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/evidence-summary.md): Evidence-based summary of polydatin in oncology, including advantages, limitations, clinical positioning, and key treatment considerations
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/anticancer-mechanisms.md): Primary anti-cancer mechanisms of Polydatin
- [G6PD Inhibition](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/anticancer-mechanisms/g6pd-inhibition.md): Polydatin G6PD inhibition, including cancer types showing particular G6PD-dependent vulnerability
- [Redox Dual Action](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/anticancer-mechanisms/redox-dual-action.md): Context-dependent polydatin redox activity explaining selective toxicity toward cancer cells while sparing normal tissues
- [NRF2 Impact](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/anticancer-mechanisms/nrf2-impact.md): Polydatin effects on the Nrf2 pathway and why that context matters in oncology
- [Ferroptosis Findings](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/anticancer-mechanisms/ferroptosis-findings.md): Emerging ferroptosis relevance of polydatin in cancer biology and treatment resistance
- [CYP1B1 Rescue Mechanism](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/anticancer-mechanisms/cyp1b1-rescue-mechanism.md): Includes Discussion of Polydatin's Unique Mechanisms for Anti-Cancer, Antimicrobial and Anti-fungal Activity
- [GLUT uptake advantage](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/anticancer-mechanisms/glut-uptake-advantage.md): Polydatin carries a glucose moiety, structurally recognised by GLUT transporters to a degree that resveratrol is not.
- [Polydatin Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type.md): Cancer-type guide to polydatin in oncology research findings, including colorectal, breast, lung, liver, oral, blood, and bone cancer research
- [Colorectal Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type/colorectal-cancer.md): Evidence-based overview of polydatin in colorectal cancer, including radiosensitisation, oxaliplatin synergy, and mechanism data
- [Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type/breast-cancer.md): Evidence-based overview of polydatin across breast cancers, including signalling effects, cautions, and
- [Lung Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type/lung-cancer.md): Evidence-based overview of polydatin in lung cancer, including apoptosis, cell-cycle arrest, and cisplatin-synergy findings
- [Liver Cancer (HCC)](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type/liver-cancer-hcc.md): Evidence-based overview of polydatin in liver cancer, including tumour selectivity, apoptosis, and chemotherapy-sensitising effects
- [Oral Cancer (OSCC)](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type/oral-cancer-oscc.md): Evidence-based overview of polydatin in oral cancer, including G6PD inhibition, anti-metastatic effects, and orthotopic model data
- [Blood Cancers](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type/blood-cancers.md): Evidence-based overview of polydatin in blood cancers, including AML and ALL findings on apoptosis, autophagy, and growth inhibition
- [Osteosarcoma](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type/osteosarcoma.md): Evidence-based overview of polydatin in osteosarcoma, including radiosensitisation, apoptosis, and doxorubicin-resistance findings
- [Other Cancer Types](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type/other-cancer-types.md): Additional polydatin oncology evidence across nasopharyngeal, cervical, ovarian, and other cancer models - work in progress
- [HER2+ Cancers](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type/her2+-cancers.md): HER2-positive breast-cancer caution for polydatin and the current Δ16HER2 / resveratrol concern
- [Immune Effects](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/immune-effects.md): Polydatin blocks G6PD, and G6PD blockade may help trigger anti-tumour immune effects
- [Antimicrobial / Antifungal Activity](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/antimicrobial-antifungal-activity.md): Polydatin antimicrobial and antifungal activity, including tumour-mycobiome relevance
- [Pharmacokinetics & Metabolism](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/pharmacokinetics-and-metabolism.md): Polydatin bioavailability, drug interactions, and delivery considerations
- [Safety & Interactions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/safety-and-interactions.md): Safety profile, interaction risks, and practical considerations for polydatin in oncology
- [Dosing & Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/dosing-and-timing.md): Polydatin dosing logic, timing, and formulation considerations in oncology use
- [Polydatin / Resveratrol Comparison](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-resveratrol-comparison.md): Comparison of polydatin and resveratrol, including mechanism, uptake, and bioavailability differences
- [Sourcing Quality Polydatin](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/sourcing-quality-polydatin.md): How to judge polydatin supplement quality, bioavailability, strength, and real-world value for oncology-oriented use
- [PDF Pack](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/pdf-pack.md): Export-friendly ordered pack for Polydatin pages
- [Shikonin in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology.md): Deep-dive guide to shikonin in oncology, including mechanisms, immune effects, evidence by cancer type, pharmacokinetics, and safety cautions
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/evidence-summary.md): Evidence-based summary of shikonin in oncology, including strengths, limitations, clinical positioning, and treatment considerations
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/anticancer-mechanisms.md): Primary anticancer mechanisms of shikonin and why they matter in oncology research
- [Immune Effects](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/immune-effects.md): How shikonin may affect immunogenic cell death, tumour-associated macrophages, and the wider tumour microenvironment
- [Shikonin Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/shikonin-evidence-by-cancer-type.md): Cancer-type guide to shikonin in oncology research across breast, bladder, oesophageal, ovarian, cervical, lung, and thyroid cancer settings
- [Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/shikonin-evidence-by-cancer-type/breast-cancer.md): Evidence-based overview of shikonin in breast cancer, including ER-pathway disruption, PKM2 relevance, necroptosis, and tamoxifen synergy
- [Bladder Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/shikonin-evidence-by-cancer-type/bladder-cancer.md): Evidence-based overview of shikonin in bladder cancer, including PKM2-driven resistance reversal, necroptosis, and cisplatin sensitisation
- [Oesophageal Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/shikonin-evidence-by-cancer-type/oesophageal-cancer.md): Evidence-based overview of shikonin in oesophageal squamous cell carcinoma, including PKM2 and STAT3-linked glycolysis suppression
- [Ovarian Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/shikonin-evidence-by-cancer-type/ovarian-cancer.md): Evidence-based overview of shikonin in ovarian cancer, including exosome biology, β-catenin signalling, and macrophage effects
- [Cervical Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/shikonin-evidence-by-cancer-type/cervical-cancer.md): Evidence-based overview of shikonin in cervical cancer, including EMT suppression and PI3K/AKT/mTOR-related findings
- [Lung Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/shikonin-evidence-by-cancer-type/lung-cancer.md): Evidence-based overview of shikonin in lung cancer, including PI3K/AKT/mTOR signalling and gefitinib sensitisation relevance
- [Thyroid Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/shikonin-evidence-by-cancer-type/thyroid-cancer.md): Evidence-based overview of shikonin in anaplastic thyroid cancer, including the current ferroptosis signal and its limits
- [Pharmacokinetics & Metabolism](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/pharmacokinetics-and-metabolism.md): Shikonin bioavailability limits, metabolism, formulation challenges, and why delivery remains the main translational barrier
- [Safety & Interactions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/safety-and-interactions.md): Shikonin safety profile, liver biology, CYP450 interaction evidence, endocrine-treatment questions, and key interaction limits in oncology use.
- [Dosing & Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/dosing-and-timing.md): What the research used, what the one human clinical signal shows, and why no established dose exists for oncology use.
- [Sourcing Quality Shikonin](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/sourcing-quality-shikonin.md): How to judge shikonin product quality, why standardisation matters, and what current market limits still look like
- [Synergistic Combinations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/synergistic-combinations.md): Preclinical shikonin combination data across endocrine therapy, chemotherapy, and targeted therapy contexts
- [Sensitisation to Conventional Therapies](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/sensitisation-to-conventional-therapies.md): How shikonin may re-open treatment sensitivity through PKM2 inhibition, ER-pathway disruption, and non-apoptotic cell death
- [PKM2 & the Warburg Effect](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/pkm2-and-the-warburg-effect.md): Why PKM2 is the central shikonin mechanism, how it links to the Warburg effect, and why that matters across cancer types
- [Shikonon's Estrogen Receptor Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/shikonin-in-oncology/shikonons-estrogen-receptor-mechanisms.md): Detailed breakdown of Shikonin's ERα, GPER, steroid-sulfatase, and downstream signalling effects in hormone-driven cancer models
- [Silymarin / Milk Thistle in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology.md)
- [Silymarin / Milk Thistle in Oncology Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-in-oncology-overview.md): What silymarin is, how it relates to milk thistle, and why it matters in oncology for liver protection, treatment support, and anticancer research
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/evidence-summary.md): Evidence-based summary of silymarin and milk thistle in oncology, including liver protection, clinical positioning, advantages, and limitations
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/anticancer-mechanisms.md): Primary anti-cancer mechanisms of silymarin and milk thistle
- [Redox Dual Action](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/anticancer-mechanisms/redox-dual-action.md): Context-dependent redox activity of silymarin and milk thistle in cancer biology
- [Silymarin / Milk Thistle Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type.md): Cancer-type guide to silymarin and milk thistle in oncology, including breast, prostate, colorectal, liver, skin, lung, pancreatic, bladder, and ovarian cancer research
- [Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type/breast-cancer.md): Evidence-based overview of silymarin and milk thistle in breast cancer, including chemotherapy support, signalling effects, and radiotherapy relevance
- [Prostate Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type/prostate-cancer.md): Evidence-based overview of silymarin and milk thistle in prostate cancer, including chemoprevention and androgen-pathway research
- [Colorectal Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type/colorectal-cancer.md): Evidence-based overview of silymarin and milk thistle in colorectal cancer, including chemotherapy synergy and PD-L1 findings
- [Liver Cancer (HCC)](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type/liver-cancer-hcc.md): Evidence-based overview of silymarin and milk thistle in liver cancer, including fasting-mimetic findings and hepatoprotective relevance
- [Melanoma and Other Skin Cancers](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type/melanoma-and-other-skin-cancers.md): Evidence-based overview of silymarin and milk thistle in skin cancer, including UV-related chemoprevention and radiodermatitis relevance
- [Lung Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type/lung-cancer.md): Evidence-based overview of silymarin and milk thistle in lung cancer, including apoptosis, cell-cycle arrest, and anti-angiogenic findings
- [Pancreatic Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type/pancreatic-cancer.md): Evidence-based overview of silymarin and milk thistle in pancreatic cancer, including proliferative signalling, apoptosis, metastasis, metabolism, and cachexia
- [Bladder Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type/bladder-cancer.md): Evidence-based overview of silymarin and bladder cancer, including effects on proliferative signalling, apoptosis, invasion and metastasis, epithelial–mesenchymal transition, and stress‑response path.
- [Ovarian Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type/ovarian-cancer.md): Evidence‑based overview of silymarin and ovarian cancer, including proliferative signalling, apoptosis and cell‑cycle arrest, EMT and metastasis, platinum sensitisation, and related gyno contexts.
- [Cervical Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/silymarin-milk-thistle-evidence-by-cancer-type/cervical-cancer.md): Evidence‑based overview of silymarin and cervical cancer, including effects on signalling, apoptosis, G2/M cell‑cycle arrest, stress‑response MAPK pathways, IC potential.
- [Chemotherapy & Radiation Synergy](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/chemotherapy-and-radiation-synergy.md): How silymarin and milk thistle may enhance treatment while protecting healthy tissue
- [Immune Modulation & PD-L1](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/immune-modulation-and-pd-l1.md): Emerging immune-oncology relevance of silymarin and milk thistle
- [Nrf2 & NF-κB Pathway Deep Dive](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/nrf2-and-nf-kb-pathway-deep-dive.md): Context-dependent pathway interpretation for silymarin and milk thistle in oncology
- [Pharmacokinetics, Bioavailability & Dosing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/pharmacokinetics-bioavailability-and-dosing.md): How silymarin and milk thistle are absorbed, processed, and dosed in research
- [Safety, Interactions & Considerations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/safety-interactions-and-considerations.md): Safety profile, interaction risks, and clinical considerations for silymarin and milk thistle
- [Sourcing & Product Quality](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/silymarin-milk-thistle-in-oncology/sourcing-and-product-quality.md): How to judge milk thistle and silymarin supplement quality, standardisation, strength, and product value for oncology-oriented use
- [Urolithin A in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology.md): Deep-dive guide to Urolithin A in oncology, including mechanisms, immune effects, evidence by cancer type, pharmacokinetics, and safety cautions
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/evidence-summary.md): Evidence-based summary of Urolithin A in oncology, including strengths, limitations, clinical positioning, and treatment considerations
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/anticancer-mechanisms.md): Primary anticancer mechanisms of Urolithin A and why they matter in oncology research
- [Immune Effects](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/immune-effects.md): How Urolithin A may affect NK cells, CD8-positive T cells, macrophage behaviour, and immunotherapy-relevant biology
- [Synergistic Combinations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/synergistic-combinations.md): How Urolithin A may combine with immunotherapy and selected standard therapies in oncology research
- [Urolithin A Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type.md): Cancer-type guide to Urolithin A in oncology research across GI, hormonal, urothelial, liver, lung, brain, prostate, and bone-cancer settings
- [Colorectal Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type/colorectal-cancer.md): Evidence-based overview of Urolithin A in colorectal cancer, including Wnt signalling, AKT1-related immune effects, apoptosis, and chemotherapy-sensitisation research
- [Pancreatic Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type/pancreatic-cancer.md): Evidence-based overview of Urolithin A in pancreatic cancer, including PI3K/AKT/mTOR suppression, stromal remodelling, gemcitabine context, and anti-PD-1 sensitisation
- [Prostate Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type/prostate-cancer.md): Evidence-based overview of Urolithin A in prostate cancer, including androgen-receptor signalling, oxidative DNA damage, NK-cell activation, and the active URO-PRO trial
- [Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type/breast-cancer.md): Evidence-based overview of Urolithin A in breast cancer, including ER-positive signalling, triple-negative macrophage effects, ABCG2 relevance, and key subtype limits
- [Endometrial Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type/endometrial-cancer.md): Evidence-based overview of Urolithin A in endometrial cancer, including ERα and ERβ modulation, G2/M arrest, and the current lack of in vivo or clinical data
- [Glioblastoma](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type/glioblastoma.md): Evidence-based overview of Urolithin A in glioblastoma, including blood-brain-barrier penetration, Sirt1-FOXO1 signalling, AKT and EGFR suppression, and tumour-microenvironment effects
- [Liver Cancer (HCC)](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type/liver-cancer-hcc.md): Evidence-based overview of Urolithin A in hepatocellular carcinoma, including β-catenin signalling, HBV-related mechanisms, Nrf2-related hepatoprotection, and gut-liver-axis relevance
- [Lung Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type/lung-cancer.md): Evidence-based overview of Urolithin A in lung cancer, including EMT inhibition, PI3K/AKT/mTOR suppression, autophagy, and in vivo xenograft findings
- [Osteosarcoma](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type/osteosarcoma.md): Evidence-based overview of Urolithin A in osteosarcoma, including anti-metastatic findings, AKT1 and EGFR relevance, and MMP2 and MMP9 suppression
- [Bladder Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/urolithin-a-evidence-by-cancer-type/bladder-cancer.md): Evidence-based overview of Urolithin A in bladder cancer, including UMUC3 sensitivity, G2/M arrest, apoptosis, and urinary-exposure relevance
- [Pharmacokinetics & Metabolism](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/pharmacokinetics-and-metabolism.md): Urolithin A bioavailability, microbiome-conversion limits, tissue-distribution questions, and supplementation implications
- [Safety & Interactions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/safety-and-interactions.md): Human safety data, drug-interaction uncertainty, endocrine cautions, and immunotherapy-related considerations for Urolithin A
- [Dosing & Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/dosing-and-timing.md): Human dose ranges, practical timing notes, and current dosing limits for Urolithin A in oncology discussions
- [Sourcing Quality Urolithin A](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/sourcing-quality-urolithin-a.md): How to judge Urolithin A supplement quality, compare real-world products, and avoid underdosed or misleading formulas
- [Antimicrobial, Antiviral & Terrain Support](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/antimicrobial-antiviral-and-terrain-support.md): Terrain-focused guide to Urolithin A across antibacterial, antiviral, antiparasitic, antifungal, gut-barrier, and microbiome-support evidence relevant to cancer care
- [Sensitisation to Conventional Therapies](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/urolithin-a-in-oncology/sensitisation-to-conventional-therapies.md): How Urolithin A may sensitise cancer cells to chemotherapy, immunotherapy, and radiation across current preclinical and early human evidence
- [Usnic Acid / Usnea](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea.md): Evidence-based overview of usnic acid from Usnea, including anticancer mechanisms, antifungal crossover, dosing context, and safety cautions
- [Usnic Acid / Usnea in Oncology Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea/usnic-acid-usnea-in-oncology-overview.md): What usnic acid is, why it is studied in oncology, and where the evidence is strongest
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea/evidence-summary.md): Evidence-based summary of usnic acid in oncology, including strengths, limitations, clinical positioning, and treatment considerations
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea/anticancer-mechanisms.md): Primary anticancer mechanisms of usnic acid and why they matter in oncology research
- [Biofilm Activity](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea/biofilm-activity.md): What usnic acid appears to do against fungal-bacterial biofilms and where its limits begin
- [Usnic Acid Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea/usnic-acid-evidence-by-cancer-type.md): Cancer-type guide to usnic acid research findings across major tumour models
- [Antifungal / Antimicrobial Activity](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea/antifungal-antimicrobial-activity.md): Usnic acid's antifungal crossover relevance and why it matters in this documentation set
- [Synergy with Standard Therapies](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea/synergy-with-standard-therapies.md): Why usnic acid has drawn interest as a possible sensitising partner with selected cancer drugs
- [Safety & Hepatotoxicity](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea/safety-and-hepatotoxicity.md): Liver-risk context, selectivity, and why dose and formulation matter so much for usnic acid
- [Dosing & Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea/dosing-and-timing.md): Practical tincture dosing context, cycling, standardisation limits, and timing considerations for usnic acid
- [Sourcing Quality Usnea / Usnic Acid](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/usnic-acid-usnea/sourcing-quality-usnea-usnic-acid.md): Product-quality considerations, standardisation problems, and example sourcing notes for usnea tinctures
- [Withaferin A (WFA) in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology.md): A detailed overview of withaferin A in oncology, including mechanisms, evidence, pharmacokinetics, safety, dosing, and sourcing.
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/evidence-summary.md): The current evidence base for withaferin A in oncology, including strengths, limitations, and clinical status.
- [Immune Effects](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/immune-effects.md): The immune and tumour-microenvironment effects of withaferin A in oncology.
- [Synergistic Combinations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/synergistic-combinations.md): Combination strategies for withaferin A, including chemotherapy, immunotherapy, and scheduling conflicts.
- [Anti-cancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/anti-cancer-mechanisms.md): The core anticancer mechanisms of withaferin A, including autophagy blockade, HSP90 disruption, vimentin targeting, and metabolic effects.
- [WFA vs Hydroxychloroquine for Autophagy Blockade](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-vs-hydroxychloroquine-for-autophagy-blockade.md): How withaferin A compares with hydroxychloroquine on mechanism, half-life, safety, pulsing, and interaction timing when autophagy blockade is the goal.
- [WFA Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type.md): A cancer-type map for withaferin A, including stronger settings such as breast and ovarian cancer and thinner exploratory areas.
- [Glioblastoma](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/glioblastoma.md): A mechanistically coherent but still thin setting for withaferin A, with relevance to HSP90, Akt/mTOR, radiosensitisation, and stem-like biology.
- [Non-Small Cell Lung Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/non-small-cell-lung-cancer.md): An emerging setting for withaferin A with evidence in EMT suppression, paclitaxel synergy, and checkpoint sensitisation.
- [Ovarian Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/ovarian-cancer.md): A leading translational setting for withaferin A because of cisplatin synergy, cancer stem cell targeting, and ongoing human trial activity.
- [Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/breast-cancer.md): The strongest disease setting for withaferin A, with direct relevance to autophagy, ER-α suppression, vimentin biology, and metastasis.
- [Other Cancer Types](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/wfa-evidence-by-cancer-type/other-cancer-types.md): A summary of additional cancer settings where withaferin A has meaningful but thinner preclinical evidence.
- [Pharmacokinetics & Metabolism](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/pharmacokinetics-and-metabolism.md): Absorption, half-life, metabolism, tissue distribution, and formulation constraints for withaferin A.
- [Sourcing Quality](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/sourcing-quality.md): How to judge whether a withaferin A product is pharmacologically coherent for oncology use.
- [Safety, Interactions and WFA Dosing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/safety-interactions-and-wfa-dosing.md): Human safety data, liver and thyroid monitoring, interaction risks, and the current dosing frame for withaferin A.
- [Hormones — ER-α and Androgens](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/hormones-er-a-and-androgens.md): What withaferin A appears to do in ER-positive breast cancer, and why older hormone-based cautions need updating.
- [Terrain Support — Liposomal WFA vs Whole-Plant Ashwagandha](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/withaferin-a-wfa-in-oncology/terrain-support-liposomal-wfa-vs-whole-plant-ashwagandha.md): When whole-plant Ashwagandha fits a cancer-support protocol, and when targeted WFA is the more coherent tool.
- [Apigenin in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology.md): Mechanisms, evidence quality, translational limits, and practical positioning for apigenin in oncology.
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/evidence-summary.md): Research scope, clinical status, strengths, and limits of the apigenin oncology evidence base.
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/anticancer-mechanisms.md): The main mechanistic routes through which apigenin shows anticancer activity in preclinical models.
- [Immune Effects](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/immune-effects.md): Preclinical immune-oncology relevance of apigenin, including PD-L1 modulation, NK-cell effects, and inflammatory signalling.
- [Synergistic Combinations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/synergistic-combinations.md): Preclinical combination data for apigenin with chemotherapy, targeted agents, BH3 mimetics, and selected natural compounds.
- [Apigenin Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/apigenin-evidence-by-cancer-type.md): Cancer settings with the strongest dedicated apigenin signals, plus shorter notes on thinner evidence areas.
- [Colorectal Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/apigenin-evidence-by-cancer-type/colorectal-cancer.md): Why colorectal cancer is one of the strongest preclinical settings for apigenin.
- [Hepatocellular Carcinoma](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/apigenin-evidence-by-cancer-type/hepatocellular-carcinoma.md): Preclinical rationale for apigenin in hepatocellular carcinoma, including pathway effects and sensitisation data.
- [Prostate Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/apigenin-evidence-by-cancer-type/prostate-cancer.md): One of the strongest mechanistic settings for apigenin, with Akt, NF-κB, EMT, and xenograft data.
- [Ovarian Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/apigenin-evidence-by-cancer-type/ovarian-cancer.md): The clearest apigenin signal in ovarian cancer is MCL-1-linked reversal of cisplatin resistance.
- [Haematological Malignancies](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/apigenin-evidence-by-cancer-type/haematological-malignancies.md): Early but mechanistically distinct apigenin data in leukaemia, myeloma, and neuroblastoma models.
- [Pharmacokinetics & Metabolism](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/pharmacokinetics-and-metabolism.md): Absorption, metabolism, transporters, tissue distribution, and the main translational bottleneck for apigenin.
- [Safety & Interactions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/safety-and-interactions.md): Safety profile, CYP and transporter interactions, and practical cautions for apigenin in treatment settings.
- [Dosing & Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/dosing-and-timing.md): Human dose context, formulation logic, and what can and cannot be inferred from the current apigenin literature.
- [Sourcing Quality Apigenin](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/sourcing-quality-apigenin.md): What makes an apigenin product credible, and where formulation quality matters most.
- [Terrain Support — SASP Suppression](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/terrain-support-sasp-suppression.md): How apigenin acts as a senomorphic compound and why SASP suppression may matter in oncology.
- [Sensitisation to Conventional Therapies](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/apigenin-in-oncology/sensitisation-to-conventional-therapies.md): How apigenin may increase sensitivity to chemotherapy and related therapies in preclinical models.
- [Terrain Support](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/terrain-support.md)
- [L. reuteri in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/terrain-support/l.-reuteri-in-oncology.md): Evidence-aware guide to Limosilactobacillus reuteri in oncology, including preclinical tumour biology, immunotherapy relevance, yoghurt preparation, capsule options, and safety cautions
- [L.reuteri hits RANKL/Bone Axis](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/terrain-support/l.-reuteri-in-oncology/l.reuteri-hits-rankl-bone-axis.md): Why L. reuteri yoghurt may be mechanistically relevant to the RANKL/OPG bone axis in ER-positive, HER2-negative breast cancer with bone involvement
- [Pu‑erh tea](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/terrain-support/pu-erh-tea.md): Evidence-aware guide to ripe Pu‑erh tea, theabrownin, metabolic terrain support, sourcing, and practical brewing
- [Integrative Practitioner Directories Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-therapies-+-clinic-offerings/integrative-practitioner-directories-overview.md): Overview of integrative oncology practitioner directories and related clinic-offering pages
- [Integrative Oncology Services and Practitioner Directories](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-therapies-+-clinic-offerings/integrative-oncology-services-and-practitioner-directories.md): Community-curated practitioner directories and related service pages for integrative oncology
- [Practitioner List: Europe & UK](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-therapies-+-clinic-offerings/integrative-oncology-services-and-practitioner-directories/practitioner-list-europe-and-uk.md): Community-curated list of integrative oncology clinics and related practitioners across Europe and the UK
- [Belgium](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-therapies-+-clinic-offerings/integrative-oncology-services-and-practitioner-directories/practitioner-list-europe-and-uk/belgium.md): Integrative oncology and practitioner entries in Belgium from the Europe and UK directory
- [Denmark](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-therapies-+-clinic-offerings/integrative-oncology-services-and-practitioner-directories/practitioner-list-europe-and-uk/denmark.md): Integrative oncology and practitioner entries in Denmark from the Europe and UK directory
- [Germany](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-therapies-+-clinic-offerings/integrative-oncology-services-and-practitioner-directories/practitioner-list-europe-and-uk/germany.md): Integrative oncology and practitioner entries in Germany from the Europe and UK directory
- [Romania](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-therapies-+-clinic-offerings/integrative-oncology-services-and-practitioner-directories/practitioner-list-europe-and-uk/romania.md): Integrative oncology and practitioner entries in Romania from the Europe and UK directory
- [Ireland](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-therapies-+-clinic-offerings/integrative-oncology-services-and-practitioner-directories/practitioner-list-europe-and-uk/ireland.md): Integrative oncology and practitioner entries in Ireland from the Europe and UK directory
- [Scotland](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-therapies-+-clinic-offerings/integrative-oncology-services-and-practitioner-directories/practitioner-list-europe-and-uk/scotland.md): Integrative oncology and practitioner entries in Scotland from the Europe and UK directory
- [Netherlands](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-therapies-+-clinic-offerings/integrative-oncology-services-and-practitioner-directories/practitioner-list-europe-and-uk/netherlands.md): Integrative oncology and practitioner entries in the Netherlands from the Europe and UK directory
- [Spain](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-therapies-+-clinic-offerings/integrative-oncology-services-and-practitioner-directories/practitioner-list-europe-and-uk/spain.md): Integrative oncology and practitioner entries in Spain from the Europe and UK directory
- [Switzerland](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-therapies-+-clinic-offerings/integrative-oncology-services-and-practitioner-directories/practitioner-list-europe-and-uk/switzerland.md): Integrative oncology and practitioner entries in Switzerland from the Europe and UK directory
- [UK](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-therapies-+-clinic-offerings/integrative-oncology-services-and-practitioner-directories/practitioner-list-europe-and-uk/uk.md): Integrative oncology and practitioner entries in the UK from the Europe and UK directory
- [Turkey](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-therapies-+-clinic-offerings/integrative-oncology-services-and-practitioner-directories/practitioner-list-europe-and-uk/turkey.md): Integrative oncology and practitioner entries in Turkey from the Europe and UK directory
- [Additional Testing Providers](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-therapies-+-clinic-offerings/integrative-oncology-services-and-practitioner-directories/practitioner-list-europe-and-uk/additional-testing-providers.md): Additional Europe-linked testing-provider entries from the practitioner directory
- [Practitioner List: New Zealand](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-therapies-+-clinic-offerings/integrative-oncology-services-and-practitioner-directories/practitioner-list-new-zealand.md): Community-curated list of integrative practitioners and clinics in New Zealand
- [Conventional Drugs; Facebook Group Support and Discussion Threads A–Z](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-therapies-+-clinic-offerings/conventional-drugs-facebook-group-support-and-discussion-threads-a-z.md): A–Z index of Healing Cancer Study Support Group discussion threads for conventional oncology drugs and related support topics
- [Off-Label Drugs for Cancer Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/off-label-drugs-for-cancer-overview.md): Overview of off-label drugs for cancer, including repurposed-drug topic hubs and practical treatment considerations
- [FLCC Approach to Repurposed Drugs in Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/flcc-approach-to-repurposed-drugs-in-cancer.md): How the two FLCC cancer-care guides fit together, and a quick dosing index for navigation
- [Mebendazole in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/mebendazole-in-oncology.md): Deep-dive guide to mebendazole in oncology, including mechanisms, cancer-type evidence, dosing, safety, and sourcing
- [Mebendazole Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/mebendazole-in-oncology/mebendazole-overview.md): What mebendazole is, why it is studied in oncology, and where the evidence is strongest
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/mebendazole-in-oncology/evidence-summary.md): Evidence-based summary of mebendazole in oncology, including strengths, limitations, clinical positioning, and treatment considerations
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/mebendazole-in-oncology/anticancer-mechanisms.md): Primary anti-cancer mechanisms of mebendazole and why it is a serious repurposing candidate
- [Mebendazole Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/mebendazole-in-oncology/mebendazole-evidence-by-cancer-type.md): Cancer-type guide to mebendazole in oncology, including ovarian, breast, colorectal, brain, lung, and other cancer research
- [Ovarian Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/mebendazole-in-oncology/mebendazole-evidence-by-cancer-type/ovarian-cancer.md): Evidence-based overview of mebendazole in ovarian cancer, including metastasis, tubulin, and Akt / NF-κB findings
- [Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/mebendazole-in-oncology/mebendazole-evidence-by-cancer-type/breast-cancer.md): Evidence-based overview of mebendazole in breast cancer, including HIF suppression, stem-like-cell effects, and hypoxia-related biology
- [Colorectal Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/mebendazole-in-oncology/mebendazole-evidence-by-cancer-type/colorectal-cancer.md): Evidence-based overview of mebendazole in colorectal cancer, including anti-VEGF signals and tolerated clinical dosing
- [Brain Tumours](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/mebendazole-in-oncology/mebendazole-evidence-by-cancer-type/brain-tumours.md): Evidence-based overview of mebendazole in brain tumours, including medulloblastoma and CNS repurposing relevance
- [Lung Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/mebendazole-in-oncology/mebendazole-evidence-by-cancer-type/lung-cancer.md): Evidence-based overview of mebendazole in lung cancer, including ERK relevance and broader signalling interest
- [Other Cancer Types](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/mebendazole-in-oncology/mebendazole-evidence-by-cancer-type/other-cancer-types.md): Additional mebendazole oncology evidence across melanoma, pancreatic, colorectal, breast, and other cancer models
- [Immune Effects](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/mebendazole-in-oncology/immune-effects.md): How mebendazole may support anti-tumour immune responses through its unusual ERK-related effects
- [Pharmacokinetics & Dosing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/mebendazole-in-oncology/pharmacokinetics-and-dosing.md): Mebendazole dosing, tolerated ranges, pharmacokinetics, and practical clinical considerations in oncology use
- [Safety & Interactions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/mebendazole-in-oncology/safety-and-interactions.md): Safety profile, tolerability, and practical interaction considerations for repurposed mebendazole in oncology
- [Sourcing Quality Mebendazole](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/mebendazole-in-oncology/sourcing-quality-mebendazole.md): Under construction — sourcing, formulation, access, and practical purchasing considerations for mebendazole in oncology
- [Itraconazole in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/itraconazole-in-oncology.md): Deep-dive guide to itraconazole in oncology, including mechanisms, cancer-type evidence, dosing, safety, and sourcing
- [Itraconazole Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/itraconazole-in-oncology/itraconazole-overview.md): What itraconazole is, why it is being repurposed in oncology, and where the evidence is strongest
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/itraconazole-in-oncology/evidence-summary.md): Evidence-based summary of itraconazole in oncology, including strengths, limitations, clinical positioning, and treatment considerations
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/itraconazole-in-oncology/anticancer-mechanisms.md): Primary anti-cancer mechanisms of itraconazole and why it is a serious repurposing candidate
- [Itraconazole Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/itraconazole-in-oncology/itraconazole-evidence-by-cancer-type.md): Cancer-type guide to itraconazole in oncology, including prostate, lung, basal cell, ovarian, breast, pancreatic, and related research
- [Prostate Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/itraconazole-in-oncology/itraconazole-evidence-by-cancer-type/prostate-cancer.md): Evidence-based overview of itraconazole in metastatic castration-resistant prostate cancer and Hedgehog-related treatment logic
- [Non-Small Cell Lung Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/itraconazole-in-oncology/itraconazole-evidence-by-cancer-type/non-small-cell-lung-cancer.md): Evidence-based overview of itraconazole in NSCLC, including pemetrexed combination data and angiogenesis relevance
- [Basal Cell Carcinoma](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/itraconazole-in-oncology/itraconazole-evidence-by-cancer-type/basal-cell-carcinoma.md): Evidence-based overview of itraconazole in basal cell carcinoma and Hedgehog-pathway relevance
- [Ovarian Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/itraconazole-in-oncology/itraconazole-evidence-by-cancer-type/ovarian-cancer.md): Evidence-based overview of itraconazole in ovarian clear cell carcinoma and chemotherapy-combination settings
- [Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/itraconazole-in-oncology/itraconazole-evidence-by-cancer-type/breast-cancer.md): Evidence-based overview of itraconazole in metastatic triple-negative breast cancer, including early clinical signal and anti-angiogenic biology
- [Pancreatic Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/itraconazole-in-oncology/itraconazole-evidence-by-cancer-type/pancreatic-cancer.md): Evidence-based overview of itraconazole in recurrent pancreatic cancer and chemotherapy-combination settings
- [Other Cancer Types](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/itraconazole-in-oncology/itraconazole-evidence-by-cancer-type/other-cancer-types.md): Additional itraconazole oncology evidence across Hedgehog-driven, angiogenesis-driven, and resistant tumour settings
- [Pharmacokinetics & Dosing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/itraconazole-in-oncology/pharmacokinetics-and-dosing.md): Itraconazole dosing, repurposed-use ranges, and practical pharmacokinetic considerations in oncology
- [Safety & Interactions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/itraconazole-in-oncology/safety-and-interactions.md): Safety profile, hepatic and cardiac cautions, and practical interaction considerations for itraconazole in oncology
- [Sourcing Quality Itraconazole](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/itraconazole-in-oncology/sourcing-quality-itraconazole.md): Under construction — sourcing, access, formulation, and practical purchasing considerations for itraconazole in oncology
- [Ivermectin in Cancer: a checklist for patients](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/ivermectin-in-cancer-a-checklist-for-patients.md): Ivermectin in cancer: a simple checklist for a more informed look
- [Aspirin in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology.md): Deep-dive guide to aspirin in oncology, including mechanisms, cancer-type evidence, dosing, safety, and immune relevance
- [Aspirin Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/aspirin-overview.md): What aspirin is, why it is studied in oncology, and where the evidence is strongest
- [Aspirin-Like Compounds](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/aspirin-like-compounds.md): How willow bark, dipyridamole, and cayenne or capsaicin compare with aspirin in platelet biology and oncology
- [Evidence Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/evidence-summary.md): Evidence-based summary of aspirin in oncology, including strengths, limitations, clinical positioning, and treatment considerations
- [Anticancer Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/anticancer-mechanisms.md): Primary anti-cancer mechanisms of aspirin and why it remains a serious repurposing candidate
- [Aspirin and Thromboxane A2 (TXA2)](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/anticancer-mechanisms/aspirin-and-thromboxane-a2-txa2.md): Why platelet-derived TXA2 matters in metastasis, immune evasion, and aspirin's anti-metastatic profile
- [Aspirin Evidence by Cancer Type](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/aspirin-evidence-by-cancer-type.md): Cancer-type guide to aspirin in oncology, including major solid tumours, myelofibrosis, and related research
- [Colorectal Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/aspirin-evidence-by-cancer-type/colorectal-cancer.md): Evidence-based overview of aspirin in colorectal cancer, including PIK3CA-selected trial data, Lynch syndrome relevance, and anti-metastatic findings
- [Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/aspirin-evidence-by-cancer-type/breast-cancer.md): Evidence-based overview of aspirin in breast cancer, including the negative Phase 3 trial, observational recurrence signals, PIK3CA relevance, and TXA2 biology
- [Gastric Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/aspirin-evidence-by-cancer-type/gastric-cancer.md): Evidence-based overview of aspirin in gastric cancer, including inflammation-related rationale, GI relevance, and current evidence limits
- [Lung Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/aspirin-evidence-by-cancer-type/lung-cancer.md): Evidence-based overview of aspirin in lung cancer, including observational signals, anti-metastatic logic, and current evidence limits
- [Endometrial Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/aspirin-evidence-by-cancer-type/endometrial-cancer.md): Evidence-based overview of aspirin in endometrial cancer, including frequency-dependent prevention signals, obesity-linked biology, and supportive survival data
- [Ovarian Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/aspirin-evidence-by-cancer-type/ovarian-cancer.md): Evidence-based overview of aspirin in ovarian cancer, including pooled prevention data, histotype-specific signals, and current evidence limits
- [Pancreatic Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/aspirin-evidence-by-cancer-type/pancreatic-cancer.md): Evidence-based overview of aspirin in pancreatic cancer, including strong prevention signals, diabetes-linked risk reduction, and platelet biology relevance
- [Glioblastoma](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/aspirin-evidence-by-cancer-type/glioblastoma.md): Evidence-based overview of aspirin in glioblastoma, including stem-cell targeting, temozolomide sensitisation, angiogenesis inhibition, and BBB-delivery limits
- [Osteosarcoma](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/aspirin-evidence-by-cancer-type/osteosarcoma.md): Evidence-based overview of aspirin in osteosarcoma, including lung-metastasis suppression, cisplatin sensitisation, NF-κB biology, and emerging PDE4D relevance
- [Prostate Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/aspirin-evidence-by-cancer-type/prostate-cancer.md): Evidence-based overview of aspirin in prostate cancer, including prevention, post-diagnosis survival, post-surgical recurrence data, and biomarker-defined subgroups
- [Liver Cancer (Hepatocellular Carcinoma)](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/aspirin-evidence-by-cancer-type/liver-cancer-hepatocellular-carcinoma.md): Evidence-based overview of aspirin in hepatocellular carcinoma, including chronic liver disease prevention, duration-dependent benefit, MASLD relevance, and the Australian NHMRC trial
- [Melanoma](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/aspirin-evidence-by-cancer-type/melanoma.md): Evidence-based overview of aspirin in melanoma, including prevention, immunotherapy-combination logic, platelet biology, and the critical high-dose Phase 2 lesson
- [Myelofibrosis](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/aspirin-evidence-by-cancer-type/myelofibrosis.md): Evidence-based overview of aspirin in myelofibrosis, including thrombosis prevention, MPN dosing issues, JAK-STAT and NF-κB overlap, and the current anti-fibrotic evidence gap
- [Other Cancer Types](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/aspirin-evidence-by-cancer-type/other-cancer-types.md): Short evidence summaries for additional aspirin cancer signals, including bladder cancer, lymphoma subtypes, cervical cancer, and important cautions
- [Pharmacokinetics & Dosing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/pharmacokinetics-and-dosing.md): Aspirin dosing context, low-dose use patterns, and practical pharmacokinetic considerations in oncology
- [Safety & Interactions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/safety-and-interactions.md): Safety profile, bleeding risk, interaction cautions, and practical oncology considerations for aspirin
- [Sourcing Quality Aspirin](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/sourcing-quality-aspirin.md): How to judge aspirin formulation, dose, access, storage, and product quality for oncology-oriented use
- [Immune Effects](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/aspirin-in-oncology/immune-effects.md): How aspirin may support anti-tumour immune activity through platelet and tumour-microenvironment effects
- [Off-Label and Re-Purposed Drugs Study Support Threads A–Z](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/off-label-and-re-purposed-drugs-study-support-threads-a-z.md): A–Z index of Healing Cancer Study Support Group conversation threads and file links for off-label and repurposed drugs
- [Breast Cancers Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/breast-cancers-overview.md): Overview of the breast-cancer space, including subtype hubs and shared cross-subtype topics
- [HER2-Positive](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive.md)
- [HER2CLIMB](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive/her2climb.md)
- [HER2CLIMB Guide](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive/her2climb/her2climb-guide.md): Central guide to HER2CLIMB resistance, testing, tucatinib clearance, and supplement-interaction pages across the site
- [HER2CLIMB Resistance Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive/her2climb/her2climb-resistance-mechanisms.md): Possible molecular and clinical mechanisms that may drive progression on the tucatinib, trastuzumab, and capecitabine regimen
- [Liquid Biopsy for HER2-Positive Resistance](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive/her2climb/liquid-biopsy-for-her2-positive-resistance.md): How ctDNA testing may help identify resistance mechanisms in HER2-positive breast cancer, including after tucatinib-based therapy
- [Tucatinib Clearance, Genetics, and Enzyme Inducers](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive/her2climb/tucatinib-clearance-genetics-and-enzyme-inducers.md): How CYP3A4, CYP2C8, genetic variation, and enzyme inducers may affect tucatinib exposure in the HER2CLIMB setting
- [Natural Compounds and CYP3A4 — HER2CLIMB Considerations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive/her2climb/natural-compounds-and-cyp3a4-her2climb-considerations.md): Practical overview of how commonly used supplements may affect CYP3A4 in the tucatinib-based HER2CLIMB regimen
- [Enhertu, Senescence, and the Senolytic Second Strike](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive/enhertu-senescence-and-the-senolytic-second-strike.md): How trastuzumab deruxtecan interacts with cellular senescence and dormancy — and why a timed senolytic strategy may matter after each cycle.
- [Should HER2+/ERα+ Patients Avoid Resveratrol or Polydatin?](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive/should-her2+-era+-patients-avoid-resveratrol-or-polydatin.md): Research note on the caution around resveratrol or polydatin in Luminal B HER2-positive, ERα-positive breast cancer
- [HER2+ Breast Cancer – Integrative Protocols](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive/her2+-breast-cancer-integrative-protocols.md): Group and support resource notes for HER2-positive breast-cancer patients exploring integrative protocols
- [Support Threads & Docs](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive/support-threads-and-docs.md): Facebook study-support threads and Google Doc links relevant to HER2-positive breast cancer
- [ER-Positive / HER2-Negative](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative.md): Estrogen-receptor-positive/HER2-negative breast cancer research summaries that need their own treatment and resistance contexts.
- [New BCL‑2 Inhibitor Trial in HR+ MBC – and Why Whack-a-Mole Still Matters](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/new-bcl-2-inhibitor-trial-in-hr+-mbc-and-why-whack-a-mole-still-matters.md): This trial is exciting because it is a much more direct attempt to force cancer cells into apoptosis than any standard of care ER+ therapy has attempted.
- [Endocrine therapy, resistance, and dormancy](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy.md)
- [CDK4/6 Options and Supplement Considerations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/cdk4-6-options-and-supplement-considerations.md): Balanced look at palbociclib, ribociclib, and abemaciclib in HR-positive disease, including supplement considerations and monitoring questions
- [SONIA Trial and CDK4/6 Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/cdk4-6-options-and-supplement-considerations/sonia-trial-and-cdk4-6-timing.md): What the SONIA phase 3 trial suggests about first-line versus second-line CDK4/6 inhibitor sequencing in HR-positive, HER2-negative advanced breast cancer
- [Galectin‑3, Cyclin D1, Modified Citrus Pectin(MCP) and CDK4/6: A Patient Guide](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/cdk4-6-options-and-supplement-considerations/galectin-3-cyclin-d1-modified-citrus-pectin-mcp-and-cdk4-6-a-patient-guide.md): This page explains how galectin‑3 (Gal‑3) connects to the same cell‑cycle pathway targeted by CDK4/6 inhibitors, and why people are talking about MCP and diet.
- [Melatonin, Palbociclib, and Cyclin D1](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/cdk4-6-options-and-supplement-considerations/melatonin-palbociclib-and-cyclin-d1.md): Preclinical ER-positive breast-cancer study suggesting melatonin may blunt palbociclib-related cyclin D1 up-regulation and deepen G1 arrest
- [Autophagy Escape in ER-Positive Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/autophagy-escape-in-er-positive-breast-cancer.md): Why mTOR pressure, glycolysis, PI3K inhibition, dormancy, and hydroxychloroquine come up in ER-positive/HER2-negative disease, with or without known TP53 status
- [Autophagy and Senescence in Antiestrogen Resistance](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/autophagy-and-senescence-in-antiestrogen-resistance.md): Plain-language guide to the 2024 review on how autophagy and reversible senescence may help ER-positive breast cancer survive endocrine therapy and CDK4/6 pressure
- [Overview and key takeaways](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/autophagy-and-senescence-in-antiestrogen-resistance/overview-and-key-takeaways.md): Plain-language overview of why autophagy and reversible senescence matter in ER-positive antiestrogen resistance
- [Endocrine therapy, CDK4/6, and why resistance still happens](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/autophagy-and-senescence-in-antiestrogen-resistance/endocrine-therapy-cdk4-6-and-why-resistance-still-happens.md): How ER-positive treatments work, where they help most, and why many cancers still find a way to survive
- [Autophagy — the first escape route](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/autophagy-and-senescence-in-antiestrogen-resistance/autophagy-the-first-escape-route.md): What autophagy is, how it works, and why it keeps showing up in ER-positive antiestrogen resistance
- [Senescence — the second escape route](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/autophagy-and-senescence-in-antiestrogen-resistance/senescence-the-second-escape-route.md): Why treatment-induced senescence can protect surviving cells, and why the review focuses on SASP and senolytics
- [Established resistance mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/autophagy-and-senescence-in-antiestrogen-resistance/established-resistance-mechanisms.md): The main mutations and bypass pathways that may accumulate while ER-positive cells survive in autophagy or senescence
- [Glossary and trial notes](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/autophagy-and-senescence-in-antiestrogen-resistance/glossary-and-trial-notes.md): Quick definitions for the main terms in this review, plus the current hydroxychloroquine-based trial landscape
- [Endocrine Therapy, Stable Disease, and Dormancy in ER-Positive Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/endocrine-therapy-stable-disease-and-dormancy-in-er-positive-breast-cancer.md): Why endocrine therapy can help hold ER-positive breast cancer in a long quiet phase, and why late reactivation can still happen
- [Slow-Growing ER+ Breast Cancer Cells and How Rac-1 and The IGF Axis Supports Relapse](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/slow-growing-er+-breast-cancer-cells-and-how-rac-1-and-the-igf-axis-supports-relapse.md): A new ER+ breast cancer paper shows that some cells survive therapy by going slow, entering a senescent‑like state and wiring in a Rac1–IGF‑axis survival circuit that supports late relapse.
- [AI Resistance and the 4-OHE1/E2 Pathway](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/ai-resistance-and-the-4-ohe1-e2-pathway.md): How 4-OHE1/E2 handling, methylation, glutathione support, elimination, and melatonin may affect aromatase-inhibitor resistance pressure
- [Blood Biopsy Trial — Getting Ahead of Treatment Resistance](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/blood-biopsy-trial-getting-ahead-of-treatment-resistance.md): How ctDNA testing and early ESR1 detection may help guide earlier treatment switching in HR-positive, HER2-negative metastatic breast cancer
- [FGFR1 Amplification in ER+ Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/fgfr1-amplification-in-er+-breast-cancer.md): A guide to the driver layer of FGFR1 amplification in ER-positive breast cancer, including endocrine resistance, ctDNA fluctuation, and what is or is not targetable today
- [Letrozole Side Effects and Possible Considerations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/letrozole-side-effects-and-possible-considerations.md): Side-effect notes and practical considerations for people using letrozole in HR-positive breast cancer
- [COMT Status and Tamoxifen](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/comt-status-and-tamoxifen.md): The crucial COMT-Tamoxifen connection in ER+ breast cancer treatment.
- [ER+/PR- Receptor Status](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/er+-pr-receptor-status.md): Research and support notes on what ER-positive, PR-negative receptor status may mean in breast cancer
- [Distinguishing Luminal A from Luminal B](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/distinguishing-luminal-a-from-luminal-b.md): Plain-language notes on the difference between Luminal A and Luminal B breast cancer and why the distinction matters
- [AR+/ER+ Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/ar+-er+-breast-cancer.md): Deep dive on androgen-receptor-positive, estrogen-receptor-positive breast cancer, including AR-dominant biology, enobosarm logic, resistance questions, and monitoring ideas
- [Fulvestrant and the Keto Diet](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/fulvestrant-and-the-keto-diet.md): Research notes on fulvestrant, metabolic context, and the ketogenic-diet question in HR-positive breast cancer
- [Genistein Dosing in ER-Positive Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/genistein-dosing-in-er-positive-breast-cancer.md): Research notes on genistein dosing questions in estrogen-receptor-positive breast cancer
- [Quercetin Notes on ER+ and Aromatase Modulation](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/quercetin-notes-on-er+-and-aromatase-modulation.md): Notes on quercetin in ER-positive breast cancer, including dose dependency, COMT activity, and aromatase questions
- [Gilbert Syndrome, UGT1A1, and Estrogen Detox](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/gilbert-syndrome-ugt1a1-and-estrogen-detox.md): Research and support notes on Gilbert syndrome, UGT1A1, and estrogen-handling questions in breast-cancer context
- [Androgen Modulation's Role in Healing Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/androgen-modulations-role-in-healing-breast-cancer.md): Notes on androgen modulation and why it may matter in breast-cancer healing and support discussions
- [Support Threads & Docs](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/support-threads-and-docs.md): Facebook study-support threads and Google Doc links that apply across breast-cancer subtypes or to broader breast-cancer questions
- [Ivermectin & ER+ Breast Cancer: What the 2026 Research Actually Found](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/ivermectin-and-er+-breast-cancer-what-the-2026-research-actually-found.md): Plain-language breakdown of the 2026 ER-positive breast-cancer study showing ivermectin effects on ESR1/ERα, HER2, TGF-β signalling, and tamoxifen synergy
- [Triple-Positive](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/triple-positive.md): Overview of triple-positive breast cancer, including what it is and where relevant support threads and overlapping subtype resources currently live
- [Triple-Negative](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/triple-negative.md): Overview of triple-negative breast cancer, including biomarkers, standard treatment logic, and common drug names used in this section
- [LAR-Subtype Triple-Negative (AR-Positive)](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/triple-negative/lar-subtype-triple-negative-ar-positive.md): Patient guide to luminal androgen receptor TNBC, including biomarkers, trial directions, and supportive research themes
- [Treatment Resistance Research](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/triple-negative/treatment-resistance-research.md): Guide to the TNBC resistance section, including natural compounds, repurposed drugs, and emerging resistance-strategy pages
- [TNBC Natural Compounds in Treatment Resistance Research](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/triple-negative/treatment-resistance-research/tnbc-natural-compounds-in-treatment-resistance-research.md): Research notes on natural compounds being explored to counter treatment resistance in triple-negative breast cancer, including pterostilbene, blueberries, and piperlongumine
- [TNBC Off-Label Drugs in Treatment Resistance Research](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/triple-negative/treatment-resistance-research/tnbc-off-label-drugs-in-treatment-resistance-research.md): Research notes on repurposed off-label drugs being explored to counter treatment resistance in triple-negative breast cancer, including pitavastatin, melatonin, and metformin
- [Emerging Resistance Strategies](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/triple-negative/treatment-resistance-research/emerging-resistance-strategies.md): Deeper look at RNA-targeting and multi-target combination strategies being explored for treatment-resistant triple-negative breast cancer
- [Post-Chemotherapy Cell Senescence Clean-up](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/post-chemotherapy-cell-senescence-clean-up.md): Study notes on post-chemotherapy senescence, lingering treatment effects, and the idea of senescent-cell clean-up in breast-cancer context
- [Dormant Cancer Cells: How to Erase Them](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/dormant-cancer-cells-how-to-erase-them.md): Study summary on breast-cancer dormancy, persistence, and the idea of targeting dormant cells
- [Lactoferrin Warning in Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/lactoferrin-warning-in-breast-cancer.md): Research notes on higher-dose lactoferrin and why it raises caution questions in breast-cancer settings
- [Collagen When Healing Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/collagen-when-healing-breast-cancer.md): Research notes on collagen in breast-cancer healing, tissue repair, and the questions this raises in treatment and recovery context
- [Radiation Post-First-Line Chemo? 2025 Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/radiation-post-first-line-chemo-2025-summary.md): Research summary on using radiation after first-line chemotherapy and how to think through that choice in breast-cancer context
- [Support Threads & Docs](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/support-threads-and-docs.md): Facebook study-support threads and Google Doc links that apply across breast-cancer subtypes or to less subtype-specific breast-cancer questions
- [Support Groups](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/support-groups.md): Groups, downloads, and community resources linked to breast-cancer research and support
- [Breast Cancer Pathways Project](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/support-groups/breast-cancer-pathways-project.md): Breast cancer pathways worksheets, download guidance, support links, and getting-started pages
- [Getting Started](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/support-groups/breast-cancer-pathways-project/getting-started.md): Step-by-step guide to using the Breast Cancer Pathways Project worksheet
- [Step 1 — Download the Worksheet](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/support-groups/breast-cancer-pathways-project/step-1-download-the-worksheet.md): How to download, copy, rename, and safely save your worksheet
- [Step 2 — Explore Your Worksheet](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/support-groups/breast-cancer-pathways-project/step-2-explore-your-worksheet.md): How to navigate tabs, understand the worksheet structure, and avoid editing the wrong fields
- [Step 3 — Standard of Care Choices](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/support-groups/breast-cancer-pathways-project/step-3-standard-of-care-choices.md): How to enter conventional treatment choices so the worksheet can populate the relevant sections
- [Step 4 — Typical Dosages](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/support-groups/breast-cancer-pathways-project/step-4-typical-dosages.md): How to interpret the worksheet dosage guidance safely and in context
- [Step 5 — Sharing Your Worksheet](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/support-groups/breast-cancer-pathways-project/step-5-sharing-your-worksheet.md): How to share your worksheet with practitioners, supporters, or community resources
- [Cancer Patient Community Supports Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-patient-community-supports/cancer-patient-community-supports-overview.md): Overview of cancer patient community supports, including books, podcasts, groups, and practical support resources
- [Free Podcasts](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-patient-community-supports/free-podcasts.md): Free podcast resources for cancer patients, carers, and integrative oncology learners
- [Books](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-patient-community-supports/books.md): Book recommendations and reading resources for cancer patients and supportive learning
- [Cancer Type Support and Discussion Threads A–Z](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-patient-community-supports/cancer-type-support-and-discussion-threads-a-z.md): A–Z index of Healing Cancer Study Support Group discussion threads organised by cancer type
- [About Abbey the Founder](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-patient-community-supports/about-abbey-the-founder.md): Background, lived experience, and community work behind My Healing Community
- [Trusted Suppliers and Discounts](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/cancer-patient-community-supports/trusted-suppliers-and-discounts.md): Why MCS Formulas is featured here, how the abbey5 code helps, and the full A–Z product list in one place
- [Pathogens Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/pathogens/pathogens-overview.md): Overview of the pathogen library, including fungal, microbial, and viral sections
- [Microbial Pathogens](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/pathogens/microbial-pathogens.md)
- [Fusobacterium nucleatum (Fn)](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/pathogens/microbial-pathogens/fusobacterium-nucleatum-fn.md)
- [Fusobacterium nucleatum (Fn) a Powerful Oncobacterium](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/pathogens/microbial-pathogens/fusobacterium-nucleatum-fn-a-powerful-oncobacterium.md)
- [Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/pathogens/microbial-pathogens/fusobacterium-nucleatum-fn-a-powerful-oncobacterium/overview.md): Overview of Fusobacterium nucleatum as an oncology-relevant microbial factor, including tumour targeting, metastasis, and practical source control
- [Why Oral Health Is an Oncology Issue Right Now](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/pathogens/microbial-pathogens/fusobacterium-nucleatum-fn-a-powerful-oncobacterium/why-oral-health-is-an-oncology-issue-right-now.md): Why oral Fusobacterium nucleatum burden matters in cancer care, including periodontal disease, root-canal source control, and practical dental steps
- [How Fusobacterium nucleatum Travels Through the Body and Finds Tumours](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/pathogens/microbial-pathogens/fusobacterium-nucleatum-fn-a-powerful-oncobacterium/how-fusobacterium-nucleatum-travels-through-the-body-and-finds-tumours.md): How Fusobacterium nucleatum enters circulation, homes to tumours, and may influence metastatic progression across multiple cancer settings
- [The Gut Microbiome — Reducing Fusobacterium nucleatum's Foothold Below the Stomach](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/pathogens/microbial-pathogens/fusobacterium-nucleatum-fn-a-powerful-oncobacterium/the-gut-microbiome-reducing-fusobacterium-nucleatums-foothold-below-the-stomach.md): How gut ecology, diet, barrier integrity, and microbiome support may help reduce Fusobacterium nucleatum pressure in cancer settings
- [Targeted Antimicrobial Drugs in Oncology](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/pathogens/microbial-pathogens/fusobacterium-nucleatum-fn-a-powerful-oncobacterium/targeted-antimicrobial-drugs-in-oncology.md): What the evidence suggests about metronidazole, 5-FU, and targeted antimicrobial pressure against Fusobacterium nucleatum in cancer settings
- [Berberine — The Most Studied Natural Compound With Direct Anti-Fusobacterium nucleatum Activity](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/pathogens/microbial-pathogens/fusobacterium-nucleatum-fn-a-powerful-oncobacterium/berberine-the-most-studied-natural-compound-with-direct-anti-fusobacterium-nucleatum-activity.md): Why berberine stands out in the Fusobacterium nucleatum literature, including tumour-microenvironment effects, pathway overlap, and interaction cautions
- [Green Tea EGCG and Dietary Polyphenols — Blocking Fusobacterium nucleatum at the Biofilm Level](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/pathogens/microbial-pathogens/fusobacterium-nucleatum-fn-a-powerful-oncobacterium/green-tea-egcg-and-dietary-polyphenols-blocking-fusobacterium-nucleatum-at-the-biofilm-level.md): How EGCG, quercetin, and curcumin may affect Fusobacterium nucleatum biofilm, adhesion, and inflammatory signalling
- [Lactobacillus reuteri — Your Most Targeted Natural Counter to Fusobacterium nucleatum](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/pathogens/microbial-pathogens/fusobacterium-nucleatum-fn-a-powerful-oncobacterium/lactobacillus-reuteri-your-most-targeted-natural-counter-to-fusobacterium-nucleatum.md): Why L. reuteri stands out in the Fusobacterium nucleatum literature, including coaggregation, biofilm disruption, and yoghurt-versus-capsule logic
- [Fusobacterium and Bone](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/pathogens/microbial-pathogens/fusobacterium-nucleatum-fn-a-powerful-oncobacterium/fusobacterium-and-bone.md): How Fusobacterium can persist in bone and bone-adjacent tissue, including osteomyelitis, chronic persistence, and practical implications
- [Viral Pathogens](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/pathogens/viral-pathogens.md)
- [Fibrotic, Hard or “Cement‑Like” Lesions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/fibrotic-hard-or-cement-like-lesions.md): Short guide to very hard, stiff, or “cement-like” tumour areas, outlining driver programme, fibrotic scaffold, and fibrin/perfusion layers and where key adjuncts fit
- [Finding Your Support Team: A Guide to Integrative Cancer Care Practitioners](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/finding-your-support-team-a-guide-to-integrative-cancer-care-practitioners.md): Guide to integrative cancer care practitioner types, what each can offer, and directories for finding qualified support worldwide
- [Fungal Pathogens Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/fungal-pathogens/fungal-pathogens-overview.md): Overview of the fungal-pathogen section, starting with the anti-fungal protocol-building worksheet
- [Anti-fungal Protocol Building Support](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support.md)
- [Expected Timeline & What to Watch For](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/expected-timeline-and-what-to-watch-for.md): Typical phases of response, rest week logic, and what changes to expect over time
- [The Problem](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/the-problem.md): Why fungal-pathogen support often needs more than a single intervention
- [Core Strategy](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/core-strategy.md): The layered model used in the anti-fungal worksheet
- [Laminarin](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/laminarin.md): Laminarin's place in the worksheet as a calming and support layer
- [Usnea Tincture](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/usnea-tincture.md): Usnea tincture's role as a fungal-weakening layer in the anti-fungal guide
- [β-Glucanase Enzymes](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/v-glucanase-enzymes.md): Enzymes positioned to break down fungal biofilm in the worksheet
- [Binders & Detox Support](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/binders-and-detox-support.md): The toxin-management and elimination layer used to help handle die-off in the worksheet
- [Antifungal Medication](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/antifungal-medication.md): The direct-kill layer in the worksheet, paired with scripts and blood tests
- [Daily Schedule](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/daily-schedule.md): Example daily timing, weekly cycling, and spacing rules for the anti-fungal guide
- [Key Fungal Players](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/key-fungal-players.md): Core fungal patterns, why they matter, and how they change protocol design
- [Monitoring & Safety Guidelines](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/monitoring-and-safety-guidelines.md): Lab monitoring, red flags, expected die-off, and practical safety support during the protocol
- [Pathogen Blood Testing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/pathogen-blood-testing.md): Direct detection, conventional fungal markers, and how blood testing can support the protocol
- [Q\&A: Pathogen β-Glucans vs Supplement β-Glucans](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/q-and-a-pathogen-v-glucans-vs-supplement-v-glucans.md): Why pathogenic fungal β-glucans and supplement β-glucans are not the same signal in practice
- [Stool Testing for Fungal Pathogens](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/stool-testing-for-fungal-pathogens.md): Stool-testing options, interpretation, susceptibility, and how gut results can guide the protocol
- [Scientific References & Further Reading](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/fungal-pathogens/anti-fungal-protocol-building-support/scientific-references-and-further-reading.md): Core papers and further reading for laminarin, usnic acid, biofilms, antifungals, and fungal-cancer links
- [Side Effects Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/side-effects/side-effects-overview.md): Overview of side-effect, symptom-support, and recovery topics across cancer therapies
- [How to use this section](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/side-effects/how-to-use-this-section.md): How to navigate the side-effects section and choose the right page
- [Constipation and Slow Gut Motility](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/side-effects/constipation-and-slow-gut-motility.md): Evidence-based deep dive on constipation and slow bowel transit in cancer care, including causes, red flags, standard management, and integrative support questions
- [Cerebral Oedema, Brain Swelling, and Radiation Necrosis](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/side-effects/cerebral-oedema-brain-swelling-and-radiation-necrosis.md): Evidence-based overview of cerebral oedema and radiation necrosis in cancer care, including what they are, why they matter, standard management, and why Boswellia is discussed in neuro-oncology
- [Neutropenia — Low White Blood Cell Count](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/side-effects/neutropenia-low-white-blood-cell-count.md): Evidence-based deep dive on neutropenia in cancer care, including causes, monitoring, red flags, standard management, and integrative support questions
- [Peripheral Neuropathy After Cancer Treatment](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/side-effects/peripheral-neuropathy-after-cancer-treatment.md): Evidence-based deep dive on treatment-related peripheral neuropathy, including causes, red flags, standard care, and integrative support questions
- [Peripheral Neuropathy — Member Experiences](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/side-effects/peripheral-neuropathy-after-cancer-treatment/peripheral-neuropathy-member-experiences.md): Community-sourced lived experience and coping strategies for treatment-related peripheral neuropathy
- [Alpha-Lipoic Acid](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/side-effects/peripheral-neuropathy-after-cancer-treatment/alpha-lipoic-acid.md): Evidence-based overview of alpha-lipoic acid as a possible adjunct for peripheral neuropathy, including mechanisms, evidence limits, and safety notes
- [Surgery Support; Before and After Care](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/surgery-support-before-and-after-care.md): Evidence-based perioperative guidance for cancer patients before and after surgery
- [Surgery — Member Experiences & Open Questions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/surgery-support-before-and-after-care/surgery-member-experiences-and-open-questions.md): Community-sourced surgery notes, member experiences, protocol summaries, and unresolved perioperative questions
- [Biopsy Support; Before and After Care](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/biopsy-support-before-and-after-care.md): Evidence-based guidance for cancer patients before and after biopsy procedures
- [Biopsy — Member Experiences & Open Questions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/biopsy-support-before-and-after-care/biopsy-member-experiences-and-open-questions.md): Community-sourced biopsy notes, member experiences, practical aftercare questions, and unresolved biopsy concerns
- [Bone Metastases](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/bone-metastases.md): Shared bone-metastasis hub covering actionable research summaries, standard bone-targeted therapies, integrative strategies, protocol notes, and community member experiences.
- [Dormant cancer cells in bone: what this 2025 review reveals](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/bone-metastases/dormant-cancer-cells-in-bone-what-this-2025-review-reveals.md): Plain-language summary of the 2025 Bakir review on bone dormancy, reactivation, and practical takeaways
- [Denosumab and Zoledronic Acid](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/bone-metastases/denosumab-and-zoledronic-acid.md): Comparison of denosumab and zoledronic acid in bone metastases, including mechanism, trade-offs, brand names, and core reference links
- [Integrative and Off-Label Strategies](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/bone-metastases/integrative-and-off-label-strategies.md): Bone-metastasis support notes on natural RANKL and NF-κB inhibitors, melatonin, propranolol, alongside ER+ andrographolide notes.
- [FOXM1 in Bone Metastasis](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/bone-metastases/foxm1-in-bone-metastasis.md): Why FOXM1 matters in metastasis, bone biology, and possible targeting strategies in bone-metastasis research
- [Bone Support and Protocol Notes](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/bone-metastases/bone-support-and-protocol-notes.md): McKinney notes, naturopathic bone-support ideas, protocol timing, and practical implementation points for bone-metastasis support
- [Group Member Tips and Supporting Evidence](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/bone-metastases/group-member-tips-and-supporting-evidence.md): Community-shared bone-metastasis tips paired with supporting evidence, including denosumab, zoledronic acid, WSZG, and D-limonene notes
- [SABR for Bone Metastases 2025 Study Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/bone-metastases/sabr-for-bone-metastases-2025-study-summary.md): Summary of the 2025 small-scale human study on SABR for bone metastases
- [Treatment Resistance Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance-overview.md): Overview of treatment-resistance, progression-pattern, and cross-cancer treatment-escape topics
- [Treatment Resistance](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance.md): Cross-cancer resistance topics, progression patterns, and treatment-escape questions
- [Treatment Resistance Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/treatment-resistance-overview.md): Overview of treatment-resistance topics that cut across cancer types, regimens, and biomarkers
- [Drug Metabolism & Supplement Interactions](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/drug-metabolism-and-supplement-interactions.md): Central landing page for pharmacogenomics, enzyme pathways, transporter logic, and supplement-interaction questions across oncology treatment settings
- [Drug Metabolism & Supplement Interactions Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/drug-metabolism-and-supplement-interactions/drug-metabolism-and-supplement-interactions-overview.md): How to organise shared CYP, transporter, inducer, inhibitor, and regimen-specific supplement interaction topics across the site
- [Dormant Cancer Cells](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells.md)
- [Dormant Cancer Cells](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells-1.md)
- [Dormant Cancer Cells](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells-2.md): Cross-cancer guide to dormancy, residual disease, reactivation risk, and treatment strategy questions
- [Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells-2/overview.md): Why dormant cancer cells matter, how the section is organised, and what questions it helps answer
- [What Dormant Cancer Cells Are](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells-2/what-dormant-cancer-cells-are.md): Plain-language guide to dormant and slow-cycling cancer cells, where they hide, and why they matter
- [Beyond Kill It All](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells-2/beyond-kill-it-all.md): Why aggressive treatment is not always the smartest answer for tiny, slow-growing, or suspected dormant disease
- [Inflammation, Stress and Dormancy Escape](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells-2/inflammation-stress-and-dormancy-escape.md): How inflammation, surgery, infection, and stress signalling can help dormant cancer cells reactivate
- [Treatment Strategies](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells-2/treatment-strategies.md): Four main ways to think about residual disease: keep dormant, wake and kill, target cells while dormant, or clear therapy-induced senescent survivors
- [Dormancy-Focused Agents and Adjuncts](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells-2/dormancy-focused-agents-and-adjuncts.md): Examples of drugs, repurposed agents, and compounds discussed in relation to dormant or slow-cycling cancer cells
- [Questions for Your Oncology Team](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells-2/questions-for-your-oncology-team.md): Practical questions that help bring dormancy biology into treatment discussions
- [Dormancy Glossary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/dormant-cancer-cells-2/dormancy-glossary.md): Quick definitions for the main terms used across the dormancy pages
- [Autophagy — Cancer's Escape Route](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/autophagy-cancers-escape-route.md): Hub last updated June 27th 2026 for autophagy-targeted cancer strategy, host protection, and emerging treatments and combination logic
- [The Early Window — Part One](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/autophagy-cancers-escape-route/the-early-window-part-one.md): Why early autophagy inhibition matters across dormant and treatment-stressed cancer states, including CDK4/6 biology, mebendazole synergy, and the senescence escape problem
- [The Multi-Target Strategy — Part Two](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/autophagy-cancers-escape-route/the-multi-target-strategy-part-two.md): How the autophagy strategy is designed to layer HCQ, AKBA, metabolic pressure, and host support across multiple cancer survival pathways
- [Protecting the Host — if HCQ is in the Protocol](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/autophagy-cancers-escape-route/protecting-the-host-if-hcq-is-in-the-protocol.md): How to think about HCQ accumulation, mitochondrial protection, monitoring, diet support, and senolytic follow-up in the autophagy strategy
- [Open Clinical Trial — COAST in Advanced Prostate Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/autophagy-cancers-escape-route/open-clinical-trial-coast-in-advanced-prostate-cancer.md): Evidence-based overview of the COAST autophagy trial in advanced solid tumours and relapsed prostate cancer, including eligibility, dose design, and why the study matters
- [Senescence — The Second Escape Route](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/treatment-resistance/treatment-resistance/senescence-the-second-escape-route.md): Hub for therapy-induced senescence, SASP biology, senolytic strategy, and safety questions in treatment-resistant cancer care
- [Testing, Monitoring & Biomarkers Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/testing-monitoring-and-biomarkers-overview.md): Overview of testing, monitoring, and biomarker topics for practical oncology use
- [Testing & Diagnostics Discussion Threads A–Z](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/testing-and-diagnostics-discussion-threads-a-z.md): A–Z index of Healing Cancer Study Support Group discussion threads on testing and diagnostics
- [Heavy Metals & Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/heavy-metals-and-cancer.md): Patient-facing guide to heavy metal burden, copper biology, testing, and practical monitoring in oncology
- [Why Heavy Metals Matter in Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/heavy-metals-and-cancer/why-heavy-metals-matter-in-cancer.md): Why heavy metal burden matters in cancer, how treatment changes metal handling, and why baseline testing can be useful
- [Pathogens, Heavy Metals & the Hidden Alliance](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/heavy-metals-and-cancer/pathogens-heavy-metals-and-the-hidden-alliance.md): How fungi, bacteria, biofilms, and heavy metals can reinforce each other in cancer settings
- [The Copper Story](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/heavy-metals-and-cancer/the-copper-story.md): Why copper often rises in active cancer and why serum copper plus ceruloplasmin can be clinically useful
- [Copper Metabolism Genes and SNPs](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/heavy-metals-and-cancer/copper-metabolism-genes-and-snps.md): Key copper transport genes that can affect copper handling, platinum chemotherapy response, and cuproptosis biology
- [Natural Support and Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/heavy-metals-and-cancer/natural-support-and-timing.md): How to think about glutathione, NAC, ALA, selenium, binders, and timing around active cancer treatment
- [Understanding Heavy Metal Testing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/heavy-metals-and-cancer/understanding-heavy-metal-testing.md): Which metal tests are most useful, what each sample type captures, and why there is no single gold standard
- [Accessing Testing Without a Referral](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/heavy-metals-and-cancer/accessing-testing-without-a-referral.md): No-referral heavy metal testing options in Australia, the UK, Canada, and the United States
- [Where to Start](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/heavy-metals-and-cancer/where-to-start.md): Practical next steps for cancer patients who want to act on heavy metal and copper questions without overcomplicating the first move
- [TP53 in Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer.md)
- [TP53 in Cancer Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/tp53-in-cancer-overview.md): Hub for TP53 test interpretation, mutation classes, treatment-planning implications, and practical support questions
- [Why Test Type Matters](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/why-test-type-matters.md)
- [TP53 SNPs and Nutrigenomics](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/tp53-snps-and-nutrigenomics.md): Common TP53 variants, rs1042522, and the wider DNA-repair context relevant to diet and lifestyle support
- [Germline TP53](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/germline-tp53.md): Inherited TP53 variants, Li-Fraumeni-spectrum risk, and why this can change treatment planning before therapy starts
- [Somatic TP53](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/somatic-tp53.md): Tumour-acquired TP53 mutations, report interpretation, and why mutation class changes treatment logic
- [TP53 Mutation Types Reference](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/somatic-tp53/tp53-mutation-types-reference.md)
- [Fenbendazole and TP53](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/fenbendazole-and-tp53.md): Why tumour p53 status can change how favourable the fenbendazole biology looks
- [Mebendazole and TP53](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/mebendazole-and-tp53.md): Why mebendazole appears less dependent on intact p53 than fenbendazole, and how TP53 status still shapes interpretation
- [Andrographis and Mutant p53](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/andrographis-and-mutant-p53.md)
- [Questions for Oncologists](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/questions-for-oncologists.md): This page gathers the most useful patient-facing questions to during the visit in which TP53 result are shared.
- [Food and Lifestyle Support](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/food-and-lifestyle-support.md)
- [NAC in p53-Mutant Cancers](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/tp53-in-cancer/nac-in-p53-mutant-cancers.md)
- [Bone Health](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/bone-health.md): Practical bone-health hub covering DXA interpretation, lab work, diet, supplementation, exercise, and reference notes.
- [Bone density testing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/bone-health/bone-density-testing.md): Practical notes on DXA interpretation, T-scores, trabecular bone score, and common scan errors.
- [Lab tests and root-cause workup](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/bone-health/lab-tests-and-root-cause-workup.md): Baseline bone-health labs, bone-turnover markers, and specialist root-cause testing notes.
- [Diet and protein](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/bone-health/diet-and-protein.md): Bone-health diet priorities, protein targets, mineral intake, and oxalate-related notes.
- [Supplementation](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/bone-health/supplementation.md): Notes on calcium, vitamin D, magnesium, K vitamins, creatine, trace minerals, collagen support, and genistein.
- [Exercise and bone loading](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/bone-health/exercise-and-bone-loading.md): Resistance training, impact loading, and key safety cautions for bone support.
- [Vitamin K2 research notes](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/bone-health/vitamin-k2-research-notes.md): Research references and caution notes on MK-4, MK-7, arterial calcification, and related bone-health questions.
- [Genistein and bone health](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/testing-monitoring-and-biomarkers/bone-health/genistein-and-bone-health.md): Research notes on genistein for bone support, including osteoporosis settings, breast-safety context, and oncology cautions.
- [The Felt Science of Thriving Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/the-felt-science-of-thriving/the-felt-science-of-thriving-overview.md): Overview of The Felt Science of Thriving and its twelve life energies
- [Presence](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/the-felt-science-of-thriving/the-felt-science-of-thriving-overview/presence.md): The gateway life energy and the first foundation practice in The Felt Science of Thriving
- [Safety (Psychological & Emotional)](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/the-felt-science-of-thriving/the-felt-science-of-thriving-overview/safety-psychological-and-emotional.md): Why psychological and emotional safety is the nervous system's prerequisite for growth, and how to access it through felt experience
- [Empathy](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/the-felt-science-of-thriving/the-felt-science-of-thriving-overview/empathy.md): Beginning with self-empathy: the act of turning toward your own inner experience with full, non-judgmental presence
- [Trust](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/the-felt-science-of-thriving/the-felt-science-of-thriving-overview/trust.md): The inner sense that life is fundamentally safe and workable, even without guarantees about outcome
- [Support](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/the-felt-science-of-thriving/the-felt-science-of-thriving-overview/support.md): The knowledge that you do not have to do this alone, and the felt experience of being genuinely supported
- [Beauty](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/the-felt-science-of-thriving/the-felt-science-of-thriving-overview/beauty.md): The felt experience of being stopped by something larger than yourself, and why beauty is a healing life energy
- [Play](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/the-felt-science-of-thriving/the-felt-science-of-thriving-overview/play.md): Why play is a universal human need, how it feels in the body, and how to access it through memory, imagination, and practice
- [Spontaneity](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/the-felt-science-of-thriving/the-felt-science-of-thriving-overview/spontaneity.md): Why spontaneity is a universal human need, how it feels in the body, and how to access it through memory, imagination, and practice
- [Safety (Physical)](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/the-felt-science-of-thriving/the-felt-science-of-thriving-overview/safety-physical.md): Coming-soon page for the physical safety life energy within The Felt Science of Thriving
- [Purpose](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/the-felt-science-of-thriving/the-felt-science-of-thriving-overview/purpose.md): Coming-soon page for the purpose life energy within The Felt Science of Thriving
- [Movement](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/the-felt-science-of-thriving/the-felt-science-of-thriving-overview/movement.md): Coming-soon page for the movement life energy within The Felt Science of Thriving
- [Belonging](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/the-felt-science-of-thriving/the-felt-science-of-thriving-overview/belonging.md): Coming-soon page for the belonging life energy within The Felt Science of Thriving


---

# Agent Instructions
This documentation is published with GitBook. GitBook is the documentation platform designed so that both humans and AI agents can read, navigate, and reason over technical content effectively. Learn more at gitbook.com.

## Querying This Documentation
If you need additional information, you can query the documentation dynamically by asking a question.
Perform an HTTP GET request on a page URL with the `ask` query parameter:
```
GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/readme.md?ask=<question>
```
The question should be specific, self-contained, and written in natural language.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.
Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.